DuPont Expands Water Solutions as Analysts Raise Price Targets on DD
DuPont de Nemours launched new electrodeionization water modules following stronger-than-expected quarterly results, an upgraded 2026 outlook, and a wave of analyst target increases.

DuPont de Nemours, Inc. has expanded its industrial water treatment portfolio by introducing four new high-flow Electrodeionization modules. The new units, designated EDI-520, EDI-820, EDI-530, and EDI-830, provide nominal product-water flow rates of 5 or 8 cubic meters per hour. Joined by the existing EDI-310 module, the lineup now covers 2 to 8 cubic meters per hour. The company designed the chemical-free, plate-and-frame technology to support high-purity water needs across industries including power generation, green hydrogen, and semiconductor manufacturing.
The product launch follows third-quarter financial results released on Tuesday, November 3rd, that topped Wall Street expectations. DuPont posted earnings per share of $2.09, beating the consensus estimate of $1.87 and rising from $1.09 in the prior-year period. Revenue reached $1.87 billion, surpassing expectations of $1.84 billion and increasing 4.1% year over year, with organic sales growing 5%. DuPont raised its full-year 2026 outlook on strong aerospace and healthcare demand and announced plans to repurchase $250 million of shares during the fourth quarter.
Following the earnings release, several brokerages lifted their price targets. UBS Group raised its objective from $172.00 to $182.00 with a buy rating. Royal Bank of Canada boosted its target from $160.00 to $173.00 while maintaining an outperform rating, and both Citigroup and Barclays raised their targets to $176.00. MarketBeat data indicates a consensus rating of Moderate Buy among analysts, with 12 rating the stock as Buy, five as Hold, and one as Sell.
Despite positive earnings, DuPont shares have experienced volatility. The stock traded down $4.93 to $145.80 on Thursday, November 5th, before rallying 5.9% on November 09, 2026, to close at $155.14. Over the past year, the shares have gained 28%, trading within a 52-week range of $111.15 to $157.98.
Valuation assessments present mixed perspectives. Zacks Investment Research recently assigned DuPont a Zacks Rank #2 (Buy). In contrast, GuruFocus assigned the stock a GF Score of 64 out of 100 and labeled it significantly overvalued, noting its $155.14 closing price sat 108.4% above its GF Value estimate of $74.43. GuruFocus also pointed to a P/E ratio of 70.1x against a 5-year median of 9.2x, alongside $0.6 million in insider share sales and no insider buying over the past 12 months.